Karin Eastham
Chairman at PERSONALIS, INC.
Net worth: 624 599 $ as of 2024-05-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Christopher Hall | M | 55 | 12 years | |
John Scarlett | M | 73 |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | 20 years |
Robert Epstein | M | 58 | 12 years | |
Marc Stapley | M | 54 | 11 years | |
Arthur Bowman | M | 77 | 17 years | |
Charles Dadswell | M | 65 | 11 years | |
Juan Estruch | M | - |
Vetica Labs, Inc.
Vetica Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Vetica Labs, Inc. engages in other industry group. The company is headquartered in San Diego, CA. | - |
Holly Smithson | F | - |
San Diego Athena
San Diego Athena Miscellaneous Commercial ServicesCommercial Services San Diego Athena operates as a not-for-profit organization. It supports and develops women. The company was founded by Barbara Bry in 1998 and is headquartered in San Diego, CA. | 7 years |
Stephane Mouradian | M | - | 7 years | |
Andrew Grethlein | M | 59 |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | 18 years |
Aaron Tachibana | M | 63 | 5 years | |
Olivia Bloom | F | 55 | 2 years | |
Jens Holstein | M | 60 | 4 years | |
Mark Ho | M | 51 | 9 years | |
Myriam Curet | M | 67 | 5 years | |
Phillip Febbo | M | 57 | 6 years | |
Evan Jones | M | 67 | 16 years | |
Dawn Bir | F | 53 | 5 years | |
Constance Maples | F | - |
San Diego Athena
San Diego Athena Miscellaneous Commercial ServicesCommercial Services San Diego Athena operates as a not-for-profit organization. It supports and develops women. The company was founded by Barbara Bry in 1998 and is headquartered in San Diego, CA. | - |
Frances Arnold | M | 67 | 8 years | |
Barbara Bry | F | - |
San Diego Athena
San Diego Athena Miscellaneous Commercial ServicesCommercial Services San Diego Athena operates as a not-for-profit organization. It supports and develops women. The company was founded by Barbara Bry in 1998 and is headquartered in San Diego, CA. | 26 years |
Diana Brainard | M | 53 | 3 years | |
Aron Feingold | M | - | 2 years | |
Muna Bhanji | F | 61 | 3 years | |
Annie McGuire | F | 44 | 2 years | |
Elizabeth Gasser | F | 48 |
San Diego Athena
San Diego Athena Miscellaneous Commercial ServicesCommercial Services San Diego Athena operates as a not-for-profit organization. It supports and develops women. The company was founded by Barbara Bry in 1998 and is headquartered in San Diego, CA. | - |
Elizabeth O'Farrell | F | 59 | 5 years | |
Grace Chui-Miller | F | - |
San Diego Athena
San Diego Athena Miscellaneous Commercial ServicesCommercial Services San Diego Athena operates as a not-for-profit organization. It supports and develops women. The company was founded by Barbara Bry in 1998 and is headquartered in San Diego, CA. | - |
Susan Molineaux | M | 70 | 12 years | |
Philip Schiller | M | 63 | 8 years | |
Gary Guthart | M | 58 | 7 years | |
Lonnie Shoff | F | 65 | 2 years | |
Caroline Dorsa | F | 64 | 7 years | |
V. Lawlis | M | 72 | 12 years | |
Woodrow Myers | M | 70 | 3 years | |
Sandra Gardiner | F | 58 | 1 years | |
Kenneth Widder | M | 71 | 1 years | |
John McDonald | M | 63 | 2 years | |
Susan Siegel | F | 63 | 5 years | |
Stephen Moore | M | 52 | 4 years | |
Robert Spiegel | M | 73 | 14 years | |
Tracy Morris | F | - | - | |
Kelly Cashion | F | - |
San Diego Athena
San Diego Athena Miscellaneous Commercial ServicesCommercial Services San Diego Athena operates as a not-for-profit organization. It supports and develops women. The company was founded by Barbara Bry in 1998 and is headquartered in San Diego, CA. | - |
Scott Ericksen | M | 52 | 11 years | |
Steven French | M | - | 2 years | |
Jonathan Wygant | M | 53 | 2 years | |
Shaye Exner | F | - |
San Diego Athena
San Diego Athena Miscellaneous Commercial ServicesCommercial Services San Diego Athena operates as a not-for-profit organization. It supports and develops women. The company was founded by Barbara Bry in 1998 and is headquartered in San Diego, CA. | - |
Lisa Haile | F | - |
San Diego Athena
San Diego Athena Miscellaneous Commercial ServicesCommercial Services San Diego Athena operates as a not-for-profit organization. It supports and develops women. The company was founded by Barbara Bry in 1998 and is headquartered in San Diego, CA. | - |
Gemini Babla | F | - |
San Diego Athena
San Diego Athena Miscellaneous Commercial ServicesCommercial Services San Diego Athena operates as a not-for-profit organization. It supports and develops women. The company was founded by Barbara Bry in 1998 and is headquartered in San Diego, CA. | - |
Fabienne Hermitte | M | - | 3 years | |
Robert Brainin | M | 53 | 3 years | |
Richard Chen | M | 53 | 13 years | |
Eliav Barr | M | 59 | 2 years | |
Deborah Jondall | F | - |
San Diego Athena
San Diego Athena Miscellaneous Commercial ServicesCommercial Services San Diego Athena operates as a not-for-profit organization. It supports and develops women. The company was founded by Barbara Bry in 1998 and is headquartered in San Diego, CA. | - |
Killu Sanborn | M | 56 |
San Diego Athena
San Diego Athena Miscellaneous Commercial ServicesCommercial Services San Diego Athena operates as a not-for-profit organization. It supports and develops women. The company was founded by Barbara Bry in 1998 and is headquartered in San Diego, CA. | - |
Rebecca Chambers | F | 46 | 3 years | |
John Leite | M | 52 | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David Greenwood | M | 72 | 16 years | |
Keith Kennedy | M | 54 | 5 years | |
John West | M | 67 | 13 years | |
Brian Atwood | M | 71 |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | 10 years |
Ted Greene | M | 81 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 22 years |
Michael Morneau | M | 58 |
SGX Pharmaceuticals, Inc.
SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA.
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | 8 years |
Stephen N. Rosenfield | M | 74 |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | 5 years |
Peter J. Fromen | M | 49 | - | |
Tina Nova | M | 70 | 9 years | |
Jeffrey Stein | M | 69 |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA.
Diversa Corp.
Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Diversa searches high and low for DNA. In its quest to develop new enzymes and other active biological compounds, the biotechnology company collects and catalogs the DNA of organisms in diverse environments (from manure piles to tropical islands). A variety of manufacturers license these compounds from the firm to develop or improve their products, which include detergents, oils, animal feeds, and pharmaceuticals. Diversa's products include enzymes for the oil and gas industry | 12 years |
Gil Labrucherie | M | 52 | 17 years | |
Alexander E. Barkas | M | 76 |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | 19 years |
David Walt | M | 71 | 18 years | |
Wendy Johnson | F | 72 |
Cytel Corp.
| 12 years |
John Schmid | M | 61 |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | 9 years |
Jonathan MacQuitty | M | 71 | 11 years | |
Francis deSouza | M | 53 | 10 years | |
Ho Young Huh | M | 54 | 8 years | |
Michael Grey | M | 71 |
SGX Pharmaceuticals, Inc.
SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | 7 years |
John Nicholson | M | 72 | 12 years | |
Marc Cluzel | M | 69 | 12 years | |
Shelly Guyer | F | 63 | 3 years | |
Brendan M. O'Leary | M | 52 |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | 5 years |
David J. Earp | M | 59 | 13 years | |
William Rastetter | M | 75 | 18 years | |
Joe C. Cook | M | 82 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 15 years |
Harry Leonhardt | M | 67 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 6 years |
Ginger Graham | F | 68 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 14 years |
Daniel Bradbury | M | 62 | 15 years | |
John Stuelpnagel | M | 66 | 11 years | |
Virgil Thompson | M | 84 |
Cytel Corp.
| 3 years |
John Thompson | M | 74 | 6 years | |
Jay Kranzler | M | 66 |
Cytel Corp.
| 6 years |
Beverly Jane Alley | F | 61 | 4 years | |
Omead Ostadan | M | 52 | 13 years | |
Gerald Heinz Möller | M | 80 |
Roche Diagnostics Corp.
Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | 7 years |
W. Todd Myers | M | 56 |
CombiChem, Inc.
CombiChem, Inc. Miscellaneous Commercial ServicesCommercial Services CombiChem, Inc. used to provide computational drug recovery services to accelerate the discovery process for new drugs and chemical compounds. The company was founded in 1994 and headquartered in San Diego, CA
SGX Pharmaceuticals, Inc.
SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | 3 years |
Carol J. Tillis | F | - | 12 years | |
Kenneth Ludlum | M | 70 | 8 years | |
Patrick Balthrop | M | 67 | 6 years | |
Matthew Onaitis | M | 53 |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | - |
Paul Ricci | M | 67 | 3 years | |
Hutan Hashemi | M | 45 |
Genoptix, Inc.
Genoptix, Inc. Medical SpecialtiesHealth Technology Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA. | 9 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 99 | 99.00% |
Germany | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Karin Eastham
- Personal Network